Login / Signup

Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care.

Sven van EgmondElla D van VlietMarlies WakkeeLoes M HollesteinXavier Ghislain Léon Victor PouwelsHendrik KoffijbergYesim MisirliRachel S L A BakkumMaarten T BastiaensNicole A KukutschAlbert J OostingElsemieke I PlasmeijerAnnik van RengenKees-Peter de RoosTamar E C NijstenEsther de VriesEsther W de Bekker-Grob
Published in: PloS one (2022)
The distribution of a personalized discharge letter decreases the number of unnecessary follow-up visits and implementing the intervention in a large eligible population would results in substantial cost savings, contributing to restraining the growing BCC costs.
Keyphrases
  • basal cell carcinoma
  • end stage renal disease
  • randomized controlled trial
  • ejection fraction
  • healthcare
  • chronic kidney disease
  • newly diagnosed
  • quality improvement
  • palliative care
  • patient reported outcomes